Clinical Trial Update: GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis [Phase 3]

View source ↗

Summary

Phase 3 double-blind and open-label study of GSK1358820 (botulinum toxin A) in axillary hyperhidrosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• GSK1358820 (Botulinum Toxin A) (botulinum toxin type A)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hyperhidrosis | Phase 3 | Status: COMPLETED | Results posted: 2012-04-25